Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors
Abstract The human gastrointestinal (GI) tract harbors gut microbiome, which plays a crucial role in preserving homeostasis at the intestinal host‐microbial interface. Conversely, specific gut microbiota may be altered during various pathological conditions and produce a number of toxic compounds an...
Main Authors: | Sama Rezasoltani, Abbas Yadegar, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-02-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3694 |
Similar Items
-
Key questions about the checkpoint blockade-are microRNAs an answer?
by: Mihnea Dragomir, et al.
Published: (2018-06-01) -
Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
by: Xinyu Yan, et al.
Published: (2018-09-01) -
Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
by: Laura Boyero, et al.
Published: (2020-12-01) -
Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors
by: Wenhui Liu, et al.
Published: (2021-02-01) -
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
by: Ming Yi, et al.
Published: (2019-03-01)